Keyphrases
Trastuzumab
100%
Metastatic Breast Cancer
100%
HER2 Expression
100%
Zirconium-89 (89Zr)
100%
PET Imaging
66%
Human Epidermal Growth Factor Receptor 2 (HER2)
66%
Expression Level
66%
89Zr-trastuzumab
66%
Tumor Growth
33%
Breast Cancer
33%
Clinical Efficacy
33%
Distant Metastasis
33%
Tumor Development
33%
Her2neu
33%
Tumor Angiogenesis
33%
HER2-positive Breast Cancer
33%
Clinical Grade
33%
Orthotopic Breast Cancer
33%
Preparation Method
33%
Therapy Selection
33%
Breast Cancer Model
33%
Anti-HER2 Antibody
33%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Tumor
100%
Trastuzumab
100%
Zirconium 89
100%
Tumor Growth
20%
Breast Cancer
20%
Distant Metastasis
20%
Cancer Model
20%
Monoclonal Antibody
20%
Epidermal Growth Factor Receptor 2
20%
Gamma Urogastrone
20%
Metastatic Breast Cancer
20%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
20%